May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
ANP and CNP Effects on IOP in Rabbits and Monkeys
Author Affiliations & Notes
  • M.A. McLaughlin
    Alcon Research Ltd, Fort Worth, TX
  • D.E. Brooks
    Univ of Florida – Gainesville, Gainesville, FL
  • D. Earnest
    Alcon Research Ltd, Fort Worth, TX
  • L. Klekar
    Alcon Research Ltd, Fort Worth, TX
  • H. Sapp
    Univ of Florida – Gainesville, Gainesville, FL
  • I.–H. Pang
    Alcon Research Ltd, Fort Worth, TX
  • M. Hellberg
    Alcon Research Ltd, Fort Worth, TX
  • W.F. Holt
    Alcon Research Ltd, Fort Worth, TX
  • Footnotes
    Commercial Relationships  M.A. McLaughlin, Alcon Research Ltd, E; D.E. Brooks, Alcon Research Ltd, F; D. Earnest, Alcon Research Ltd, E; L. Klekar, Alcon Research Ltd, E; H. Sapp, None; I. Pang, Alcon Research Ltd, E; M. Hellberg, Alcon Research Ltd, E; W.F. Holt, Alcon Research Ltd, E.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 412. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.A. McLaughlin, D.E. Brooks, D. Earnest, L. Klekar, H. Sapp, I.–H. Pang, M. Hellberg, W.F. Holt; ANP and CNP Effects on IOP in Rabbits and Monkeys . Invest. Ophthalmol. Vis. Sci. 2006;47(13):412.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To evaluate atrial natriuretic peptide (ANP) and C–type natriuretic peptide (CNP) ocular injection effects on intraocular pressure (IOP) in rabbits and to determine IOP effects of CNP in nonhuman primates.

Methods: : The peptides were injected intracamerally (IC) or intravitreally (IVT) in Dutch belted (DB) rabbits, cynomolgus monkeys, and rhesus monkeys with unilateral trabeculoplasty resulting in ocular hypertension. Dosing was unilateral drug with contralateral vehicle. Rabbits were anesthetized for IC injection; monkeys for both IC and IVT injection. IOP was measured at intervals post–dose by applanation tonometry. Monkeys were lightly anesthetized for tonometry; rabbits were fully conscious. IVT data were calculated as change from same day baseline (time=0); IC data as difference from vehicle eyes at the same time point.

Results: : IC: ANP (10, 20 µg) and mini–ANP (10, 30, 100 µg) did not alter IOP in DB rabbit (n=7–10, p>0.05). CNP (10 µg) did not lower IOP in DB rabbits (n=10) or cynomolgus monkeys (n=4, p=0.2). IVT: ANP (40 µg) and mini–ANP (100 µg) lowered IOP a maximum of 30.9% and 15% respectively in DB rabbits (n=7–9, p=0.001). CNP gave a dose response effect in the DB rabbit with maximum IOP reduction of 25% (1 µg, n=7, p=0.01), 43% (10 µg, n=10, p=0.001), and 47% (50 µg, n=6, p=0.001). Duration of IOP lowering increased with dose; no effect lasted to 48 hours. CNP (50 µg) in the rhesus monkey lowered IOP 20% in lasered eyes (n=6, p=0.05) compared to baseline.

Conclusions: : The natriuretic peptides and their receptors have been speculated to be involved in the regulation of IOP based on receptor presence in ocular tissues and IOP studies in rabbits, monkeys, and humans. We did not reproduce IOP lowering with intracameral ANP or CNP in rabbits. Intravitreal ANP and CNP lower IOP in both rabbit and lasered monkey. Duration of effect appears dose–related.

Keywords: intraocular pressure • pharmacology • receptors 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.